Asthma is not prone to hike the risk of a person contacting COVID – 19 or impact its severity as indicated by a team of Rutgers researchers.
“Older age and conditions such as heart disease, high blood pressure, chronic obstructive pulmonary disease, diabetes and obesity are reported risk factors for the development and progression of COVID-19,” said Reynold A. Panettieri Jr., a pulmonary critical care physician and director of the Rutgers Institute for Translational Medicine and Science and co-author of a paper published in the Journal of Allergy and Clinical Immunology. “However, people with asthma — even those with diminished lung function who are being treated to manage asthmatic inflammation — seem to be no worse affected by SARS-CoV-2 than a non-asthmatic person. There is limited data as to why this is the case — if it is physiological or a result of the treatment to manage the inflammation.”
Panetteri informs what we are aware about asthma and inflammation and the essential questions that still require to be answer.
HOW MIGHT AWARENESS OF SARS – COV-2 AFFECT THE HEALTH OF PEOPLE WITH ASTHMA?
As the news has concentrated our perception on the impacts of COVID -19 on people who are vulnerable. The people suffering from asthma may tend to become more vigilant about personal cleanness and observing social distancing. The social distancing can better asthma management as people are self quarantined and not exposed to seasonal changes that makes include allergens of respiratory viruses. Also there is evidence that people are more vigilant in taking their asthma medicines during the course of the pandemic, which can improve overall health.
WHAT EFFECTS MIGHT OF INHALED STEROIDS HAVE ON COVID – 19 OUTCOMES?
Inhaled corticosteroids, which are commonly used to protect against asthma attacks, also may reduce the virus’s ability to establish an infection. However, studies have shown that steroids may decrease the body’s immune response and worsen the inflammatory response. Steroids also have been shown to delay the clearing of the SARS and MERS virus — similar to SARS-CoV-2 — from the respiratory tract and thus may worsen COVID-19 outcomes. Future studies should address whether inhaled steroids in patients with asthma or allergies increase or decrease the risks of SARS-CoV-2 infection and whether these effects are different depending on the steroid type.